Aurora Cannabis received a cultivation license from Health Canada for its 40,000-square-foot indoor facility in Pointe-Claire, making it only the second company to have a medical marijuana production license in Quebec.
An executive told Marijuana Business Daily that production from the facility – called “Aurora Vie” – will be used to meet local and global MMJ demand, starting with Germany and the European Union.
“We have soaring demand in Germany right now and additional EU medical cannabis markets coming online,” said Cam Battley, executive vice president of Aurora, which is based in Alberta and traded on the Toronto Stock Exchange as ACB.
Here’s what you need to know about Aurora Vie:
- The facility has a projected cultivation capacity of approximately 4,000 kilograms of cannabis per year.
- The company anticipates its first harvest in early 2018.
- The medical cannabis will be distributed in Germany through Pedanios, its wholly owned subsidiary.
- Aurora purchased the facility in April for 7 million Canadian dollars ($5.4 million). Since then, Aurora has put another CA$3 million into the facility to meet EU manufacturing standards.
To sign up for our weekly Canada marijuana business newsletter, click here.